Non-Helium Magnetoencephalography in Pediatric Brain Tumors
ConditionPediatric Brain Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age3-18
SponsorGuangzhou Women and Children's Medical Center
About this trial
This observational study aims to evaluate the effectiveness of magnetoencephalography (MEG) in the preoperative assessment of pediatric brain tumors, particularly in determining the extent of resection, and compare it with computed tomography (CT) and magnetic resonance imaging (MRI).
The main questions this study aims to answer are:
What is the consistency between MEG and CT/MRI in localizing pediatric brain tumors? What is the clinical efficacy of MEG in determining the extent of resection of pediatric brain tumors preoperatively?
Participants will:
Undergo both MEG and CT/MRI examinations for preoperative assessment, and the extent of tumor resection will be determined by the comprehensive results of the above examinations.
Be followed up with MEG and CT/MRI at 1, 3, and 6 months after surgery, along with neurological and quality-of-life assessments.
Eligibility criteria
Qualifiers
Age range: 3-18 years old;
Clinically diagnosed with brain tumor;
Capable of cooperating with magnetoencephalography evaluation and recording.
Disqualifiers
Patients with serious comorbidities or neurological or psychiatric disorders that affect magnetoencephalography examination.
Patients using drugs that affect central nervous system function;
Patients who are not suitable for surgical procedures;
Patients with progressive neurological disorders.
Trial design
Treatments tested in this trial
- Magnetoencephalography plus Computed Tomography/Magnetic Resonance Imaging
Treatment groups
No treatment groups listed
Sponsors and collaborators
Guangzhou Women and Children's Medical Center
Lead sponsor
Beijing X-Magtech Technology Limited
Collaborator
Source ClinicalTrials.gov